Navigation Links
Two New Imaging Studies Show Higher Dose Lipitor Stopped the,Progression of Atherosclerosis

red with pravastatin as measured by IVUS.

According to Dr Michael Berelowitz, Senior Vice President of Pfizer's global medical division, "These results support previous studies where higher doses of Lipitor have demonstrated impact on atherosclerosis. However, while imaging findings are scientifically interesting, we know that physicians make clinical decisions based on proven cardiovascular outcomes."

Lipitor Offers Remarkable Benefit for Stroke Patients

In a new separate analysis from a landmark clinical trial known as the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL), patients without heart disease, who had suffered a recurrent stroke or mini-stroke during the trial and took Lipitor 80 mg had a significant 53 percent reduction in the risk of major coronary events (death from cardiac causes, heart attack, or resuscitation after cardiac arrest).

"This is the first time a statin has been shown to provide coronary benefit for patients with recent stroke or mini-stroke," said Professor Henrik Sillesen, chairman of the department of vascular surgery at the University of Copenhagen in Denmark. "What is impressive is the magnitude of benefit seen with Lipitor in these high risk patients. The results show that aggressive lipid lowering with Lipitor addresses an unmet medical need."

"This adds to the wealth of scientific evidence which has consistently shown improved cardiovascular outcomes in a broad range of patients. Lipitor is the only statin that offers a unique and robust body of evidence that includes proven reductions in heart attacks and stroke, impressive average LDL lowering of 39 to 60 percent, and an established safety profile across a broad range of patients," said Dr Berelowitz.

Summary of Imaging Trials Results for the Lipitor Arm

The three, two-year clinical trials, involving over 2,800 patients were designed to investigate the efficacy of torcetrapib in combination with Lipitor co
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
2. Repligen Reports Positive Phase 2 Clinical Trial Results of Secretin for MRI Imaging of the Pancreas
3. Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimers Disease Presented at AD/PD Meeting
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
6. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
7. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
8. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
9. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
10. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
11. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
Post Your Comments:
(Date:9/23/2014)... , Sept. 23, 2014 ... of the "Physician Office Laboratory Markets, 3rd ... This report, Physician Office Laboratory Markets is ... the IVD industry. Physician office laboratories are diverse ... simply perform reimbursable, in-office pregnancy and glucose tests. ...
(Date:9/23/2014)... , Sept. 23, 2014 The Pennsylvania State ... Sat., Sept. 27, as part of National Prescription Drug ... questions asked. Take-Back Day is a national ... Administration (DEA), aimed at encouraging the public to dispose ... prone to abuse and theft. From 10 ...
(Date:9/23/2014)... 23, 2014 Research and Markets ... Vaccine Production Markets" report to their offering. ... and vaccines - including products to treat cancer, diabetes, ... challenges during the final stages of clinical drug testing ... to risk production capital to upscale while anticipating FDA ...
Breaking Medicine Technology:Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3
... Top-line Data to be Released Concurrent with November 9 AHA Data ... ... (Nasdaq: VIAP ), a biotechnology company focused on the development of,compounds ... last patient visit in its Phase 2 acute coronary,syndrome (ACS) study, including ...
... and Efficacy of ORMD 0801, Oral Insulin Capsule, ... on Type 1 ... http://www.oramed.com ), a developer,of oral delivery systems, announced today that it has ... 1 diabetics at the,Hadassah University Medical Center in Jerusalem, Israel., Oramed,s ...
Cached Medicine Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 4Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics 2
(Date:9/23/2014)... York (PRWEB) September 23, 2014 Mirena ... injury due to spontaneous migration of the birth control ... Bernstein Liebhard LLP reports. According to court documents dated ... that alleges migration of the IUD outside of the ... rectum. Her lawsuit, which is now pending in the ...
(Date:9/23/2014)... 2014 Mel Frank, also known as ... and harvesting marijuana. He is perhaps one of the ... he’ll be leading a special elective course on growing ... pm at Oaksterdam University in Oakland, California. ... nomenclature, harvesting and manicuring, and identifying preflowers and outdoor ...
(Date:9/23/2014)... Florida Hospital Zephyrhills officially celebrates the ... Center on Wednesday, September 24. With more than ... center offers a new level of personalized care ... Health Center offers comprehensive women’s services including gynecology, ... through The Baby Place®, and breast care through ...
(Date:9/23/2014)... TO CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF OPIOIDS ... WHAT: , The National Institutes of Health is convening ... scientific evidence on the long-term effectiveness and potential risks ... among the nation,s top experts in the field of ... well as key NIH scientists who focus on pain ...
(Date:9/23/2014)... (PRWEB) September 24, 2014 From first-hand ... disorder (PTSD) – and how it can be treated. ... deployed in Iraq in 2006. His platoon sustained multiple ... 2008, he was diagnosed with combat-related PTSD and honorably ... was angry, and I had distanced myself from my ...
Breaking Medicine News(10 mins):Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 2Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 3Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 4Health News:Special Elective Course Added to Oaksterdam University Schedule; Unique Opportunity to Learn From the “Godfather of Cannabis” Mel Frank on September 27, 2014 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3
... Former Steeler Robin Cole to Appear , , ... be Saturday, August 8, as Experience LEBO and Miller Lite present ... party event, from 8 p.m. to midnight. , , ... to literally party in the street-- Rt. 19/Washington Road closes to vehicular traffic ...
... , FERNDALE, Wash., July 28 Nearly 64 ... vitamin D - a nutrient found to support the immune system, bone strength, ... , manufacturers of a liquid vitamin D3 supplement. , , ... aware that sunscreen, even at SPF15, blocks more than 90 percent of the ...
... , , , ... health care providers and nonprofit health plans, announced today that it ... more than 700 nonprofit agencies nationwide in the second quarter of ... access to high-quality care to uninsured and underserved communities, healthy food ...
... , , LOS ANGELES, ... of next generation digital media protection and intelligence solutions, today ... technology platform to ensure network protection and data security for ... companies, pharmaceutical companies, hospitals, physician practices, and more. In ...
... study by researchers at the Georgetown,s Lombardi Comprehensive Cancer Center ... urine of children with acute lymphoblastic leukemia (ALL), a cancer ... age. The findings are published in the August issue ... caution that these findings should not be seen as cause-and-effect, ...
... , EAST RUTHERFORD, N.J., July 28 Cambrex Corporation (NYSE: CBM ) announced ... closes. , , The Company will host a conference call to discuss the ... Second Quarter 2009 Earnings Conference Call, ... 5, 2009 at 8:30 a.m. Eastern Time, Dial-in: ...
Cached Medicine News:Health News:Mt. Lebanon Comes Alive Saturday, August 8th with ULTRAparty 2Health News:Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production 2Health News:Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production 3Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 2Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 3Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 4Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 5Health News:Nexicon Technology to Protect Healthcare Industry 2Health News:Nexicon Technology to Protect Healthcare Industry 3Health News:Nexicon Technology to Protect Healthcare Industry 4Health News:Nexicon Technology to Protect Healthcare Industry 5Health News:Common household pesticides linked to childhood cancer cases in Washington area 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: